U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 1,583 records

Showing results for "liver".
Users also searched for: hepatitis c

  1. Hodgkin Disease | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/health-topics/hodgkin-disease

  2. Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings: Systematic Review Update (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/alcohol-pharma-final-protocol.pdf
    January 01, 2023 - The damage may be either physical (e.g., liver damage from chronic drinking) or mental/social (e.g. … rates of early mortality.19-21 They are associated with hypertension, heart disease, stroke, cancer, liver

  3. Wireless-Motility-Capsule Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
    May 01, 2013 - Am J Physiol Gastrointest Liver Physiol. 2009;297(6):G1107-14. PMID: 19808653. 49. … Am J Physiol Gastrointest Liver Physiol. 2010;299(6):G1276-86. PMID: 20847301. 65.

  4. Strategies To Prevent Weight Gain in Adults: Future Research Needs (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-future_research.pdf
    January 01, 2020 - authors included cardiovascular disease, diabetes mellitus, infertility, degenerative joint disease, and liver … ClinicalTrials.gov/show/NCT00169702 Recently Completed Effect of Dietary and Life Style Modification on Post Liver

  5. Hypertension-Pulmonary-Arterial Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
    April 01, 2013 - sensitivity 0.91 [95% CI, 0.85 to 0.94]; specificity 0.91 [95% CI, 0.85 to 0.94]) included 4 studies of liver … (This is shown in studies of liver transplant patients with complete verification).

  6. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)

    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfannrpt2011.pdf
    January 01, 2012 - Fortunately most people who have the infection do not develop liver problems. … understand the progression of the disease and which individuals are at highest risk of suffering from liver

  7. Integrating Stakeholder Preferences in Comparative Effectiveness Research: Potential Uses of Multi-Criteria Decision Analysis Techniques (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
    August 27, 2012 - How far would we have to increase the risk of liver failure to take away that 0.84 gain in benefit from … and the answer is that patients would tolerate up to a little more than 2% increase in the chance of liver

  8. Evidence Summary: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/statin-use-in-adults-preventive-medication
    August 23, 2022 - increased risk of withdrawal because of adverse events, serious adverse events, cancer, or elevated liver … additional CHD risk factor Excluded: use of lipid-lowering therapy, intolerant of statins, significant liver

  9. Archived: Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    April 11, 2016 - Gut Liver . 2008;2:99-104. [PMID: 20485618] 31. … which are prevalent and/or may be affected by aspirin use in terms of benefits or harms: diabetes, liver

  10. Follow-up Visits for Children Who Are Obese or Overweight with a Weight-Related Comorbidity: Report (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0242-fullreport.pdf
    February 01, 2020 - broad spectrum of serious health issues, including obstructive sleep apnea, asthma, nonalcoholic fatty liver … Gastrointestinal problems include nonalcoholic fatty liver disease (NAFLD), which is related to both

  11. CHIPRA 230: Documentation of BMI Percentile and Weight Classification for Children (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-230-fullreport.pdf
    July 01, 2019 - broad spectrum of serious health issues, including obstructive sleep apnea, asthma, nonalcoholic fatty liver … Gastrointestinal problems include nonalcoholic fatty liver disease (NAFLD), which is related to both

  12. Making Healthcare Safer IV_Rapid Response: Reducing Adverse Drug Events Related to Anticoagulant Use in Adults (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
    January 01, 2024 - Other risks of anticoagulant use include liver injury,17 minor bleeding,18 and dermatologic effects.19 … patients on DOACs, including urea and electrolytes (3 monthly to annually), full blood count, and liver … Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation

  13. Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary19/colorectal-cancer-screening
    May 18, 2021 - Dig Liver Dis . 2012;44(8):700-704. doi:10.1016/j.dld.2012.03.015 63. … Dig Liver Dis . 2017;49(5):557-561. doi:10.1016/j.dld.2016.12.020 114. … Dig Liver Dis . 2013;45(8):645-650. doi:10.1016/j.dld.2013.02.020 191.

  14. HEALTHCARE COST AND UTILIZATION PROJECT — HCUP (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2013.pdf
    January 01, 2013 - Hypothyroidism: (1) comorbidity present, (0) comorbidity not present CM_LIVER AHRQ comorbidity measure - Liver … 37,987 17.16 17.53 2.2 15: Cancer of rectum and anus 12,496 21.26 21.68 2.0 16: Cancer of liver … abscess 8,092 27.39 28.28 3.2 149: Biliary tract disease 107,986 14.87 15.38 3.4 151: Other liver

  15. THE HCUP NATIONWIDE READMISSIONS DATABASE (NRD), 2014

    hcup-us.ahrq.gov/db/nation/nrd/NRD_Introduction_2010-2014.jsp
    January 01, 2014 - : (1) comorbidity present, (0) comorbidity not present CM_LIVER AHRQ comorbidity measure - Liver … 17.53 2.2 15: Cancer of rectum and anus 12,496 21.26 21.68 2.0 16: Cancer of liver … 27.39 28.28 3.2 149: Biliary tract disease 107,986 14.87 15.38 3.4 151: Other liver

  16. Research Protocol: Safety of Vaccines Used for Routine Immunization in the United States (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
    January 30, 2020 - pneumococcal and influenza vaccines to prevent serious health complications in adults with chronic liver … Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis

  17. Screening for Lipid Disorders in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/rQBBkz9CrHh4vp7ZnEkF-t
    July 18, 2023 - Clinical importance of transient elevations in these laboratory values is unknown Low for reversible liver … Limited longer-term evidence shows few withdraw- als due to adverse events, slightly higher rates of liver

  18. Archived: Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
    November 13, 2016 - serious adverse events (RR, 0.99 [95% CI, 0.94 to 1.04]), myalgias (RR, 0.96 [95% CI, 0.79 to 1.16]), or liver-related … increased risk of withdrawal because of adverse events, serious adverse events, cancer, or elevated liver

  19. Financial and Demographic Influences on Medicare Patient Safety Events (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Bernard.pdf
    January 01, 2004 - .: Liver Disease 0.007 Peptic Ulcer Disease X Bleeding 0.010 AIDS 0.00004 Lymphoma 0.005 Metastatic

  20. What Happens After a Patient Safety Event? Medical Expenditures and Outcomes in Medicare (pdf file)

    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Encinosa.pdf
    January 01, 2003 - Variables PSI No PSI Hypothyroidism 0.012 0.013 Renal failure 0.020 0.057 Liver disease 0.003
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

hcup-us.ahrq.gov (496)

effectivehealthcare.ahrq.gov (343)

psnet.ahrq.gov (259)

www.uspreventiveservicestaskforce.org (230)

www.ahrq.gov (171)

digital.ahrq.gov (57)

cds.ahrq.gov (15)

integrationacademy.ahrq.gov (4)

meps.ahrq.gov (4)

cdsic.ahrq.gov (1)

datatools.ahrq.gov (1)

pso.ahrq.gov (1)

qualityindicators.ahrq.gov (1)